0
Cosmetic Breast Augmentation and Suicide
David B. Sarwer, Ph.D.; Gregory K. Brown, Ph.D.; Dwight L. Evans, M.D.
CME   Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of Suicidal Events in the FDA’s Pediatric Suicidal Risk Analysis of Antidepressants
Kelly Posner, Ph.D.; Maria A. Oquendo, M.D.; Madelyn Gould, Ph.D., M.P.H.; Barbara Stanley, Ph.D.; Mark Davies, M.P.H.
Relationship Between Antidepressants and Suicide Attempts: An Analysis of the Veterans Health Administration Data Sets
Robert D. Gibbons, Ph.D.; C. Hendricks Brown, Ph.D.; Kwan Hur, Ph.D.; Sue M. Marcus, Ph.D.; Dulal K. Bhaumik, Ph.D.; J. John Mann, M.D.
Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
Joseph P. McEvoy, M.D.; Jeffrey A. Lieberman, M.D.; Diana O. Perkins, M.D., M.P.H.; Robert M. Hamer, Ph.D.; Hongbin Gu, Ph.D.; Arthur Lazarus, M.D., M.B.A.; Dennis Sweitzer, Ph.D.; Christina Olexy; Peter Weiden, M.D.; Stephen D. Strakowski, M.D.
Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison
Richard S.E. Keefe, Ph.D.; John A. Sweeney, Ph.D.; Hongbin Gu, Ph.D.; Robert M. Hamer, Ph.D.; Diana O. Perkins, M.D.; Joseph P. McEvoy, M.D.; Jeffrey A. Lieberman, M.D.
Relative Glucose Metabolic Rate Higher in White Matter in Patients With Schizophrenia
Monte S. Buchsbaum, M.D.; Bradley R. Buchsbaum, Ph.D.; Erin A. Hazlett, Ph.D.; M. Mehmet Haznedar, M.D.; Randall Newmark, B.A.; Cheuk Y. Tang, Ph.D.; Patrick R. Hof, M.D.
Volumetric White Matter Abnormalities in First-Episode Schizophrenia: A Longitudinal, Tensor-Based Morphometry Study
Thomas J. Whitford, B.Sc., Ph.D.; Stuart M. Grieve, B.Sc., Ph.D.; Tom F.D. Farrow, B.Sc., Ph.D.; Lavier Gomes, M.B.B.S., F.R.A.N.C.R., B.D.S., B.Sc.; John Brennan, M.B.B.S.B.S.C., F.R.A.N.Z.C.P.; Anthony W.F. Harris, M.B.B.S., F.R.A.N.Z.C.P, Ph.D.; Evian Gordon, M.B.B.Ch., B.Sc., Ph.D.; Leanne M. Williams, B.A., Ph.D.
Bipolar Affective Puerperal Psychosis: Genome-Wide Significant Evidence for Linkage to Chromosome 16
Ian Jones, M.R.C.Psych., Ph.D.; Marian Hamshere, Ph.D.; Jeanne-Marrie Nangle, M.R.C.Psych.; Philip Bennett, Ph.D.; Elaine Green, Ph.D.; Jess Heron, B.A.; Ricardo Segurado, Ph.D.; David Lambert, Ph.D.; Peter Holmans, Ph.D.; Aiden Corvin, M.R.C.Psych., Ph.D.; Mike Owen, F.R.C.Pysch., Ph.D.; Lisa Jones, Ph.D.; Michael Gill, F.R.C.Psych., Ph.D.; Nick Craddock, F.R.C.Psych., Ph.D.
Identification of Functional Polymorphisms in the Promoter Region of the Human PICK1 Gene and Their Association With Methamphetamine Psychosis
Daisuke Matsuzawa, M.D.; Kenji Hashimoto, Ph.D.; Ryosuke Miyatake, M.D., Ph.D.; Yukihiko Shirayama, M.D., Ph.D.; Eiji Shimizu, M.D., Ph.D.; Kazuhisa Maeda, M.D., Ph.D.; Yoichi Suzuki, M.D., Ph.D.; Yoichi Mashimo, M.S.; Yoshimoto Sekine, M.D., Ph.D.; Toshiya Inada, M.D., Ph.D.; Norio Ozaki, M.D., Ph.D.; Nakao Iwata, M.D., Ph.D.; Mutsuo Harano, M.D., Ph.D.; Tokutaro Komiyama, M.D., Ph.D.; Mitsuhiko Yamada, M.D., Ph.D.; Ichiro Sora, M.D., Ph.D.; Hiroshi Ujike, M.D., Ph.D.; Akira Hata, M.D., Ph.D.; Akira Sawa, M.D., Ph.D.; Masaomi Iyo, M.D., Ph.D.
Is Cocaine Desire Reduced by N-Acetylcysteine?
Steven D. LaRowe, Ph.D.; Hugh Myrick, M.D.; Sarra Hedden, M.S.; Pascale Mardikian, M.D.; Michael Saladin, Ph.D.; Aimee McRae, Pharm.D.; Kathleen Brady, M.D., Ph.D.; Peter W. Kalivas, Ph.D.; Robert Malcolm, M.D.
CME   Early Psychosocial Intervention Following Traumatic Events
Jonathan I. Bisson, D.M., F.R.C.Psych.; Mark Brayne, M.A.; Frank M. Ochberg, M.D.; George S. Everly, Jr., Ph.D.
Human White Matter Atlas
Susumu Mori, PH.D.; Peter van Zijl, PH.D.
Possession
Ronald Ruskin, M.D., F.R.C.P.(C.), Dip. Psych.